REDWOOD SHORES, Calif., Jan. 17,
2018 /PRNewswire/ -- Oracle Health Sciences today
announced the results of a new study, conducted in partnership with
Informa Engage, which reveals the top challenges and frustrations
for clinical trial professionals with current Randomization and
Trial Supply Management/ Interactive Response Technology (RTSM/IRT)
systems, as well as opportunities for improvement. Among the many
findings, the study revealed the top three challenges in RTSM/IRT
for over 70 percent of respondents: integration with other
platforms, slowness to build, test and deploy new trials, and lack
of flexibility and inability to support study changes.
Clinical trials are known for being complex and lengthy, and
trial set up can account for a large portion of the time. Exploring
the reasons for delay, the study found that 92% of respondents
reported having to make changes to their RTSM/IRT systems due to
study changes, and on an average of two times per study. Given
these results, it's no wonder that over half of the respondents
believe they could conduct more trials if they were able to
leverage self-service capabilities to build new trials and make
mid-study changes on their own.
In addition, the survey revealed that the most anticipated
change in RTSM/IRT within the next five years is the integration of
IRT into the eClinical platform, followed by accelerated trial
builds, and completely self-service solutions, which reflects a
desire for the top current challenges to be addressed in the next
generation of RTSM/IRT platforms.
"When you're developing software to help people with a specific
business process, such as clinical research, it's important to stay
in tune with the market to ensure you're always innovating to
address their top challenges and delighting them with a solution
that makes their job easier," said Steve
Rosenberg, general manager, Oracle Health Sciences. "The
findings from this research confirm the pain points that we address
with our new Clinical One Randomization and Supplies Management
Cloud Service and that we are aligned with what the market wants in
a modern RTSM/IRT solution."
Oracle recently announced Oracle Clinical One, a cloud-based
eClinical environment that is intended to redefine the way
technology supports clinical research. Its first module, Clinical
One Randomization and Supplies Management, was designed with
self-service in mind, enabling clinical teams to design, validate
and deploy a study in days with the click of a button, effectively
addressing the issues identified in this study.
The study, whose goal was to identify the top challenges facing
users of RTSM/IRT solutions, highlights many of the issues
important to clinical operations and trial management
professionals. Data was gathered via an online survey completed by
254 professionals in clinical operations, trial management and
related functional areas with direct involvement in both Clinical
Trial Operations and RTSM/IRT solutions.
Additional Resources
- Oracle Health Sciences Clinical One
- Clinical One Randomization and Supplies Management
- **Images from Informa Engage October
2017 Oracle Health Sciences Survey
About Oracle
The Oracle Cloud offers complete SaaS application suites for ERP,
HCM and CX, plus best-in-class database Platform as a Service
(PaaS) and Infrastructure as a Service (IaaS) from data
centers throughout the Americas, Europe and Asia. For more information about Oracle
(NYSE:ORCL), please visit us at oracle.com
Trademarks
Oracle and Java are registered trademarks
of Oracle and/or its affiliates. Other names may be trademarks of
their respective owners.
View original content with
multimedia:http://www.prnewswire.com/news-releases/oracle-health-sciences-study-reveals-top-challenges-and-opportunities-for-rtsmirt-solutions-300583558.html
SOURCE Oracle